Support us
Schinkel
Alfred Schinkel

Alfred Schinkel

Group leader

Email

For specifics on my CV, please see also under “Work Experience”.

Starting in 1997, my group has been studying genes and proteins that affect drug resistance in tumors, or influence the pharmacological and toxicological behavior of (anticancer) drugs and toxins, including carcinogens. Of special interest are multispecific drug efflux and uptake transporters, as well as drug-metabolizing enzymes. Insight into these systems may: i) improve pharmacotherapy approaches for cancer and other diseases; ii) increase insights into factors determining susceptibility to toxins and carcinogens, and; iii) allow elucidation of physiological functions. To understand the roles of these proteins we often generate and analyze knockout or transgenic mice lacking or overexpressing the relevant genes.


Fields of expertise

Pharmacokinetics

Drug transport

Drug metabolism

Work experience

Education
Master’s degree (MSc) in Biology/Biochemistry (cum laude): June 1983, University of Amsterdam. Qualification to teach senior secondary pupils / high-school students in botany and zoology.

Ph.D. (cum laude): University of Amsterdam, January 11, 1989 on the thesis entitled: "Mitochondrial RNA polymerase of yeast" under the supervision of Prof. Dr. H.F. Tabak.


Research appointments
2007 - date
Tenured staff member, project leader “C”, The Netherlands Cancer Institute (equivalent to “full professor”).

2002 - 2007
Tenured staff member, project leader “B”, The Netherlands Cancer Institute (equivalent to “associate professor”).

1996 - 2002
Staff member (AvL fellow), The Netherlands Cancer Institute (equivalent to “assistant professor”).

1996 - 1997
Visiting Research Scientist, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Sponsor: Michael M. Gottesman, M.D., Chief.

1988 - 1996
Postdoctoral investigator at the Netherlands Cancer Institute. Subject: Multidrug resistance and P-glycoproteins. Research group leader: Prof. Dr. P. Borst.

1983 - 1988
Ph.D. thesis research on structure and function of the mitochondrial RNA polymerase of Saccharomyces cerevisiae, carried out under the supervision of Prof. Dr. H.F. Tabak, University of Amsterdam.

Administrative functions
2018 - date
Division Head, Division of Pharmacology, The Netherlands Cancer Institute.

2004 - 2008
Division Head, Division of Experimental Therapy, The Netherlands Cancer Institute.

2004 - 2007
Secretary of NKI Research Council.

2002 - 2007
Chairman internal NKI Animal User’s Committee.

Teaching
Lectures and tutorials as part of the NKI Course on Experimental Oncology.

Supervision of graduate and undergraduate students.

Awards
2014
Named 2014 Thomson Reuters “Highly Cited Researcher” in the area of Pharmacology and Toxicology: belonging to the 1% most highly cited researchers in this research area (2002-2012). Website: www.highlycited.com

1995
Antoni van Leeuwenhoek Prize 1994 for research on the biological role of P-glycoproteins involved in multidrug resistance.

1995
Dutch Galenus Prize 1993 for work on P-glycoprotein and its role in the blood-brain barrier.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.